Overview
Aplastic Anemia is a rare blood disorder characterized by a decrease in the production of blood cells. This can lead to a decrease in the number of red blood cells, white blood cells, and platelets. Symptoms include fatigue, shortness of breath, bruising, and frequent infections. It is typically treated with immunosuppressants, bone marrow transplants, and/or blood transfusions. Left untreated, Aplastic Anemia can be fatal. Its significance lies in its rarity, with only about two thousand cases reported in the United States per year, and its prognosis, which is dependent on the severity of the disorder and the specific treatments available. Treatment for Aplastic Anemia requires significant resources, both in terms of cost and personnel. As such, it is a major concern for the medical community, not only for the well-being of individuals diagnosed with the disorder, but also to ensure a competent medical system is able to respond.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 12 articles above have been cited 39 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Journal of Medicine, University of Santo Tomas
-
2024 ·
-
2022 · Eastern Ukrainian Medical Journal
-
2022 · Eastern Ukrainian Medical Journal
-
2022 · Current Applied Science and Technology
-
2021 · Open Access Journal of Cardiology
-
2021 · International Journal of Global Health
-
2021 · Cell & Cellular Life Sciences Journal
A sample of recent works citing this journal's research on Aplastic Anemia, linking to each citing work.